CLBFX
Price
$37.44
Change
+$0.11 (+0.29%)
Updated
Sep 3 closing price
Net Assets
256.45B
FBAKX
Price
$31.87
Change
+$0.19 (+0.60%)
Updated
Sep 3 closing price
Net Assets
58.76B
Interact to see
Advertisement

CLBFX vs FBAKX

Header iconCLBFX vs FBAKX Comparison
Open Charts CLBFX vs FBAKXBanner chart's image
American Funds American Balanced 529F
Price$37.44
Change+$0.11 (+0.29%)
VolumeN/A
Net Assets256.45B
Fidelity Balanced K
Price$31.87
Change+$0.19 (+0.60%)
VolumeN/A
Net Assets58.76B
CLBFX vs FBAKX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CLBFX vs. FBAKX commentary
Sep 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLBFX is a Buy and FBAKX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CLBFX has more cash in the bank: 256B vs. FBAKX (58.8B). CLBFX pays higher dividends than FBAKX: CLBFX (1.94) vs FBAKX (1.72). CLBFX was incepted earlier than FBAKX: CLBFX (23 years) vs FBAKX (17 years). CLBFX (0.67) is less costly to investors than FBAKX (0.39). CLBFX is a more actively managed with annual turnover of: 44.00 vs. FBAKX (24.00). FBAKX has a lower initial minimum investment than CLBFX: FBAKX (0) vs CLBFX (250). CLBFX annual gain was more profitable for investors over the last year : 8.62 vs. FBAKX (8.06). CLBFX return over 5 years is better than : 41.04 vs. FBAKX (26.94).
CLBFXFBAKXCLBFX / FBAKX
Total Expense Ratio0.670.39172%
Annual Report Gross Expense Ratio0.670.39172%
Fund Existence23 years17 years-
Gain YTD10.2008.201124%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets256B58.8B435%
Annual Yield % from dividends1.941.72113%
Returns for 1 year8.628.06107%
Returns for 3 years39.0332.38121%
Returns for 5 years41.0426.94152%
Returns for 10 years92.7762.82148%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PTHS27.805.34
+23.78%
Pelthos Therapeutics Inc
HRMY37.550.45
+1.21%
Harmony Biosciences Holdings
STN108.770.53
+0.49%
Stantec
PNNT7.190.01
+0.14%
Pennant Investment Corp
ASNS0.43-0.03
-5.76%
Actelis Networks